Guangdong Hengrui Pharmaceutical Co., Ltd

This early-stage study tests a new drug called SHR-4712 in 15 people with advanced solid tumors that have not responded to other treatments. The main goals are to check the drug's safety and how the body processes it. Participants receive the drug until their disease worsens or s…

This study tests an experimental injection called SHR-1819 for adults with moderate to severe atopic dermatitis (eczema). The goal is to see if it can clear skin rashes and reduce itching better than a placebo. 652 participants are taking part in this Phase 3 trial, which is the …

This study tests an experimental injection called SHR-3045 in 30 adults with moderate to severe rheumatoid arthritis who did not get enough relief from standard treatments. The goal is to see if it safely reduces joint pain and swelling. Participants are randomly assigned to rece…

This early-stage study tests how a new drug (SHR-1819) enters the body when injected with different devices. It involves 160 healthy adults aged 18-55. The goal is to compare the drug's absorption and safety across devices, not to treat any disease.